SEC Form 4 · accession 0000897069-26-001472
Processa Pharmaceuticals, Inc. · PCSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin W Yorke
Director
Period of report
Jun 26, 2026
Accepted (ET)
Jun 30, 2026 · 4:49 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001533743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 26, 2026 | M | 203 | — | A | 353 | D | |
| Common Stock | holding | — | — | — | 1,250 | I | By Richland Fund, LLC | |
| Common Stock | holding | — | — | — | 496 | I | By Directed Trust Company FBO Justin Yorke IRA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted StockF1 | $0.00 | Jun 26, 2026 | M | 203 | D | — | — | Common Stock | 203 | 5,249 | D |
Explanation of responses
- F1Distribution of time-based service award.